Herantis Pharma Oyj Statistics

Total Valuation

Herantis Pharma Oyj has a market cap or net worth of EUR 33.27 million. The enterprise value is 29.81 million.

Market Cap	33.27M
Enterprise Value	29.81M

Important Dates

The next estimated earnings date is Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Herantis Pharma Oyj has 20.16 million shares outstanding. The number of shares has increased by 10.24% in one year.

Current Share Class	n/a
Shares Outstanding	20.16M
Shares Change (YoY)	+10.24%
Shares Change (QoQ)	+15.35%
Owned by Insiders (%)	9.16%
Owned by Institutions (%)	56.87%
Float	14.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	16.31
P/TBV Ratio	16.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-48.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.01.

Current Ratio	2.30
Quick Ratio	2.28
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -661.79% and return on invested capital (ROIC) is -5.09%.

Return on Equity (ROE)	-661.79%
Return on Assets (ROA)	-2.75%
Return on Capital (ROIC)	-5.09%
Revenue Per Employee	n/a
Profits Per Employee	-55,651
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.40% in the last 52 weeks. The beta is 0.32, so Herantis Pharma Oyj's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+4.40%
50-Day Moving Average	1.41
200-Day Moving Average	1.48
Relative Strength Index (RSI)	67.72
Average Volume (20 Days)	66,771

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-193,631
Pretax Income	-612,160
Net Income	-612,160
EBITDA	n/a
EBIT	-193,631
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 3.49 million in cash and 30,000 in debt, giving a net cash position of 3.46 million or 0.17 per share.

Cash & Cash Equivalents	3.49M
Total Debt	30,000
Net Cash	3.46M
Net Cash Per Share	0.17
Equity (Book Value)	2.04M
Book Value Per Share	0.10
Working Capital	2.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.95M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Herantis Pharma Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.24%
Shareholder Yield	-10.24%
Earnings Yield	-1.97%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a